Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eeAjCfbwoceYhBdxhjuP

  ADVERTISEMENT  
January 10, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • Why some potential donors of bone marrow and stem cells say no
    Most potential donors of bone marrow and blood stem cells who decline to donate after being identified were ambivalent in some way about the process, according to a recent study reported in the journal Blood. Screening could identify and address doubts and concerns early in the process, researchers said. CNN/The Chart blog (1/9) LinkedInFacebookTwitterEmail this Story
 
  ADVERTISEMENT  
How much do you hate your anti-Fyb?
Tired of sub-par reactions? Quotient has a newly approved anti-Fyb, as well as hard-to-find Anti-s, Anti-Wra and other rare antisera that are worth a try. Find out how the one company focused on manual testing can serve you in 2013 and beyond.

  Science & Health 
  • Flu outbreak prompts Boston to declare public emergency
    Boston Mayor Thomas Menino on Wednesday declared a public health emergency. The city has recorded 10 times the number of flu cases so far this season as in the entire previous flu season. Officials will provide residents free vaccinations. "This is the worst flu season we've seen since 2009, and people should take the threat of flu seriously," Menino said. MedicalDaily.com/Reuters (1/9) LinkedInFacebookTwitterEmail this Story
  • Diabetes raises post-angioplasty stent thrombosis risk
    Data on 6,298 heart attack patients who had their first angioplasty revealed those with diabetes had higher rates of second heart attack, stent thrombosis, repeat revascularization and death compared with those who did not have diabetes. The results were published in Diabetes Care. DailyRx.com (1/9) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • U.S. life expectancy, health status lag
    Americans have shorter average life expectancy than people in other developed nations and are more likely to engage in unhealthy behaviors such as consuming high-fat, high-calorie diets, according to a report released by the National Research Council and Institute of Medicine. Researchers also said the U.S. fared poorly on metrics such as obesity and diabetes, infant mortality and teen pregnancy when compared with 16 other countries. Reuters (1/9), WebMD (1/9) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • How to refine medical error reporting
    The U.S. health system spends about $17.29 billion in avoidable expenses each year because of medical errors, many of which go unreported. This article offers three steps to enhance the way medical errors are reported: integrating medical error reporting into EHR systems, adopting mobile technologies that include ways to capture and report medical error data, and using data analytics. Government Health IT online (1/7) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • Mostashari discusses ONC priorities, gives a glimpse of stage 4 MU
    National Health IT Coordinator Dr. Farzad Mostashari said during a meeting of the Health IT Policy Committee that the Office of the National Coordinator for Health IT's work this year will fall into three categories: improving how meaningful use is implemented, solving interoperability challenges and supporting consumer use of health information. The meeting also included a look at stage 4 of the meaningful use program. "You might think of stage 4 as moving toward the learning health system for both professionals and patients, so that we make better and better use of data," said committee vice chairman Dr. Paul Tang. Healthcare Informatics online (1/8) LinkedInFacebookTwitterEmail this Story
  • FDA, state officials probe another Mass. compounding pharmacy
    The FDA joined Massachusetts officials in a surprise inspection of an unnamed pharmacy similar to the New England Compounding Center, which was tied to a national fungal meningitis outbreak. "The FDA has authority over certain things and if they feel this registrant is performing business practices in their domain, that's their call," said Dr. Madeleine Biondolillo, director of the state's Bureau of Health Care Safety and Quality. Cease-and-desist orders have been issued to at least four drug compounders since the start of the surprise inspections. The Boston Globe (tiered subscription model)/White Coat Notes blog (1/8) LinkedInFacebookTwitterEmail this Story
  Association News 
  • 2 books available in the AABB Marketplace
    Two books are available in the AABB Marketplace. The fourth edition of "Transfusion Reactions" is a prominent reference manual on noninfectious complications addressing clinical presentation, morbidity, differential diagnosis, mechanism of action, treatment and prevention for each type of complication. The book contains a new chapter addressing prevention strategies and the role of patient blood management. "Clinical Research: Understanding the Methodology Toolbox" is a compilation of evidence-based research articles that originally appeared as a feature, titled "Clinical Research Focus," in the journal "Transfusion." Written by recognized experts, the book provides guidance on how to design, perform and publish the clinical research needed to fill some of the voids in scientific literature. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
Director of Quality SystemsRock River Valley Blood CenterUS - IL - Rockford
DIRECTOR, COMMUNITY CENTER IUnited Blood ServicesUS - NV - Reno
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
Clinical Lab Specialist IICreative Testing SolutionsUS - FL - St. Petersburg
Click here to view more job listings.

  SmartQuote 
Luck enters into every contingency. You are a fool if you forget it -- and a greater fool if you count upon it."
--Phyllis Bottome,
British writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information